Stomach Paralysis (Gastroparesis) Weight Loss & Diabetes Drug Lawsuits
Gastroparesis (Stomach Paralysis) Lawsuits
The recent surge in popularity of weight loss and diabetes drugs like Ozempic, Wegovy, Mounjaro, Saxenda, Trulicity, and Rybelsus has raised significant concerns over their potential side effects, particularly gastroparesis, or “stomach paralysis.” This condition, characterized by delayed gastric emptying and affecting the nerves and muscles in the stomach, can be extremely serious and even life-threatening. Riddle & Brantley is actively investigating these claims — if you’ve been diagnosed with this condition after taking one of these popular weight loss or diabetes drugs, you may qualify for a gastroparesis (stomach paralysis) lawsuit.
For a FREE, no-obligation case review concerning a potential diabetes or weight loss drug lawsuit, please call 1-800-525-7111 or complete the fast and easy form below. There are never any upfront costs, and you won’t pay any attorney fees unless we win your case and you receive compensation.
Stomach Paralysis (Gastroparesis) Weight Loss & Diabetes Drug Lawsuits Guide
- Potentially Linked Diabetes and Weight Loss Drug Brands
- Do Diabetes & Weight Loss Drugs Cause Stomach Paralysis (Gastroparesis)?
- Claims Against Ozempic, Wegovy, and Other Weight Loss and Diabetes Drug Makers
- Do You Have a Stomach Paralysis Claim Against a Diabetes and Weight Loss Drug Manufacturer?
Potentially Linked Diabetes and Weight Loss Drug Brands
Research and consumer claims have revealed a potential link between popular diabetes and weight loss drugs. Brands potentially linked to increased gastroparesis / stomach paralysis risk include:
- Ozempic
- Wegovy
- Mounjaro
- Saxenda
- Trulicity
- Rybelsus
IMPORTANT: Drug manufacturers have strongly denied any liability and/or wrongdoing associated with gastroparesis claims, and no settlements have been made in stomach paralysis lawsuits or claims as of January 2024.
What is Gastroparesis?
Gastroparesis, often referred to as stomach paralysis, is a condition characterized by the delayed emptying of the stomach’s contents into the small intestine. This impairment in gastric motility is due to a disruption in the normal activity of the stomach muscles. The condition can result in a range of symptoms that significantly impact a person’s quality of life.
Gastroparesis (Stomach Paralysis) Symptoms
According to the Mayo Clinic, symptoms of gastroparesis (stomach paralysis) include:
- Vomiting
- Nausea
- Abdominal bloating
- Abdominal pain
- A feeling of fullness after eating just a few bites
- Vomiting undigested food eaten a few hours earlier
- Acid reflux
- Changes in blood sugar levels
- Lack of appetite
- Weight loss and malnutrition
IMPORTANT: If you’ve experienced any of these symptoms, or think you may be suffering from gastroparesis, contact your healthcare provider immediately.
Do Diabetes & Weight Loss Drugs Cause Stomach Paralysis (Gastroparesis)?
Recent research indicates that the active ingredients in popular diabetes and weight loss drugs may cause gastroparesis (stomach paralysis).
A study published in JAMA on October 5, 2023, highlighted the increased risk of serious gastrointestinal conditions, including gastroparesis, associated with GLP-1 inhibitor weight-loss medications such as Wegovy and Ozempic. The study found that nearly 5 in every 1,000 users of semaglutide (the active ingredient in Wegovy, Ozempic, and Rybelsus) developed pancreatitis (another condition we’re investigating concerning potential claims), and roughly 9 cases of gastroparesis were observed among every 1,000 users of semaglutide. For comparison, only about 3 in every 1,000 users of bupropion-naltrexone, a different weight-loss drug, experienced stomach paralysis.
Claims Against Ozempic, Wegovy, and Other Weight Loss and Diabetes Drug Makers
The first individual lawsuits related to stomach paralysis were filed in August of 2023. Legal analysts expect thousands of patients to come forward with similar claims. These lawsuits are not class action but rather individual cases that may be consolidated in a multidistrict litigation court (MDL), allowing each affected individual to exercise more control over their case and potentially receive higher award amounts.
In one recent case, a Louisiana woman filed a product liability lawsuit against the makers of Ozempic and Mounjaro, claiming she was “severely injured” after using them. The lawsuit alleges that the companies failed to adequately warn about the risk of gastroparesis. The plaintiff, Jaclyn Bjorklund, used Ozempic for over a year and then switched to Mounjaro, only to suffer severe gastrointestinal events, including vomiting, stomach pain, and hospitalizations.
If you’ve suffered from gastroparesis (stomach paralysis) after using Ozempic, Wegovy, Mounjaro, Saxenda, Trulicity, or Rybelsus, you may be entitled to compensation. Call 1-800-525-7111 today for a free case review and let’s see if you may qualify for a weight loss or diabetes drug stomach paralysis lawsuit.
Failure to Warn and FDA Action
These stomach paralysis claims allege that manufacturers “failed to warn” consumers about the potential risks of these medications. In September 2023, the U.S. Food & Drug Administration (FDA) approved new warnings for labels on diabetes and weight loss drugs like Ozempic that detailed the potential risk of blocked intestines.
These actions follow other investigations by the FDA, which have centered on potential risks of hair loss, aspiration (inhalation of food or objects into the airway), and suicidal ideation.
Do You Have a Stomach Paralysis Claim Against a Diabetes and Weight Loss Drug Manufacturer?
Stomach Paralysis (Gastroparesis) Weight Loss & Diabetes Drug Lawsuits Lawyer, Gene Riddlenot
You may qualify for a gastroparesis lawsuit against diabetes and weight loss drug makers if you took a qualifying medication and suffered from one or more of the following conditions:
- Stomach paralysis (gastroparesis)
- Pancreatitis
- Pancreatic cancer
- Persistent vomiting
- Persistent nausea and diarrhea
- Stomach not working
Riddle & Brantley is actively investigating these claims and we would love to help you get justice if you qualify for a claim. Please call 1-800-525-7111 for a FREE, no-obligation case review with an experienced dangerous drugs attorney handling Ozempic, Wegovy, Mounjaro, and other claims.
Since 2000 alone, we’ve secured over $725 million for victims (see disclaimer below), and we’d love to help however we can.
“This settlement changed me and my family’s lives.”
–Linda B., Riddle & Brantley client
*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.